Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-25wd4 Total loading time: 0 Render date: 2024-04-26T02:23:21.232Z Has data issue: false hasContentIssue false

2 - Introduction and history of polycystic ovary syndrome

Published online by Cambridge University Press:  29 September 2009

Cindy Farquhar
Affiliation:
University of Auckland
Gabor T. Kovacs
Affiliation:
Monash University, Victoria
Robert Norman
Affiliation:
University of Adelaide
Get access

Summary

Since the classical observation of Stein and Leventhal in 1935 (Stein and Leventhal 1935), interest in polycystic ovaries (PCO) and its associated syndrome (PCOS) has evolved from a “gynaecological curiosity to a multisystem endocrinopathy” (Homburg 1996). It is probably the most common endocrine disorder in women, accounting for the majority of cases of hirsutism, of menstrual disturbance, and anovulatory infertility. It is also one of the most poorly defined endocrinological conditions with a complex pathophysiology that has produced considerable scientific debate. Evidence of the ongoing interest in this disorder is not difficult to find; an electronic search on medline from 1966 to 2005 using the search term “polycystic ovary syndrome” produces 5112 citations; 934 are review articles, and 200 are randomized controlled trials (Fig. 2.1), and the majority of publications occur after 1985.

Recognition

Although Stein and Leventhal were first in the modern medicine era to describe this condition, an earlier description dating back to 1721 reads: “Young married peasant women, moderately obese and infertile, with two larger than normal ovaries, bumpy, shiny and whitish, just like pigeon eggs.” (Vallisneri 1721; translated from Italian.) There was further recognition in the nineteenth century when sclerocystic changes in the ovary were described (Chereau 1844), but it was not until Stein and Leventhal first presented their paper at the Central Association of Obstetricians and Gynecologists in 1935 that the syndrome was more comprehensively described.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Adams, J., Franks, S., Polson, D. W., et al. (1985) Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 2:1375–1379.CrossRefGoogle ScholarPubMed
Adams, J., Polson, D. W., and Franks, S. (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br. Med. J. 293:355–359.CrossRefGoogle ScholarPubMed
Adashi, E. Y., Resnick, C. E., D'Ercole, J., Svoboda, M. E., and Wyk, J. J. (1985) Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr. Rev. 6:400–420.CrossRefGoogle ScholarPubMed
Adashi, E. Y., Resnick, C. E., and Hernandez, E. R. (1988) Insulin-like growth factor 1 as an implifier of FSH: studies on mechanism(s) and site(s) of action in cultured rat granulosa cells. Endocrinology 122:1583–1591.CrossRefGoogle ScholarPubMed
Ardaens, Y., Robert, Y., Lemaitre, L., et al. (1991) Polycystic ovarian disease: contribution of vaginal endosonography and reassessment of ultrasonic diagnosis. Fertil. Steril. 55:1062–1068.CrossRefGoogle ScholarPubMed
Balen, A. H., Conway, G. S., Kaltsas, G., et al. (1995) Polycystic ovary syndrome: The spectrum of the disorder in 1741 patients. Hum. Reprod. 10:2107–2111.CrossRefGoogle ScholarPubMed
Barbieri, R. L., Makris, A., Randall, R. W., et al. (1986) Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism. J. Clin. Endocrinol. Metab. 62:904–910.CrossRefGoogle ScholarPubMed
Barnes, R. B., Rosenfield, R. L., Burstein, S., and Ehrmann, D. A. (1989) Pituitary–ovarian responses to nafarelin testing in the polycystic ovary syndrome. N. Engl. J. Med. 320:559–565.CrossRefGoogle ScholarPubMed
Bayram, N., Wely, M., Kaaijk, E. M.Bossuyt, P. M., and Veen, F. (2004) Using an electrocautery strategy or recombinant follicle stimulating hormone to induce ovulation in polycystic ovary syndrome: randomized controlled trial. Br. Med. J. 328:192–195.CrossRefGoogle ScholarPubMed
Bergh, C., Carlsson, B., Olsson, J. H., Selleskog, U., and Hiullensjo, T. (1993) Regulation of androgen production in activated human thecal cells by IGF-1 + insulin. Fertil. Steril. 59:323–331.CrossRefGoogle Scholar
Birdsall, M., Farquhar, C. M., and White, H. (1997) Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. Ann. Intern. Med. 126:32–35.CrossRefGoogle ScholarPubMed
Botsis, D., Kassanos, D., Pyrgiotis, E., and Zourlas, P. A. (1995) Sonographic incidence of polycystic ovaries in a gynecological population. Ultrasound Obstet. Gynecol. 6:182–185.CrossRefGoogle Scholar
Bringer, J., Lefebvre, P., Boulet, F., et al. (1993) Body composition and regional fat distribution in polycystic ovarian syndrome: relationship to hormonal and metabolic profiles. Ann. N. Y. Acad. Sci. 687:115–123.CrossRefGoogle ScholarPubMed
Bunker, C. B., Newton, J. A., Conway, G. S., et al. (1991) The hormonal profile of women with acne and polycystic ovaries. Clin. Exp. Derm. 16:420–423.CrossRefGoogle ScholarPubMed
Burghen, G. A., Givens, J. R., and Kitabehi, A. E. (1980) Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J. Clin. Endocrinol. Metab. 50:113–116.CrossRefGoogle ScholarPubMed
Cara, J. F. and Rosenfield, R. (1988) Insulin-like growth factor-1 and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal–interstitial cells. Endocrinology 123:733–739.CrossRefGoogle ScholarPubMed
Carey, A. H., Chank, L., Short, F., et al. (1993) Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin. Endocrinol. (Oxf.) 38:653–658.CrossRefGoogle ScholarPubMed
Chang, R. J., Nakamura, R. M., Judd, H. L., and Kaplan, S. A. (1983) Insulin resistance in non-obese patients with polycystic ovarian disease. J. Clin. Endocrinol. Metab. 57:356–359.CrossRefGoogle Scholar
Chereau, A. (1844) Mémoire pur Servir a l'Etude des Maladies des Ovaries. Paris: Fortin, Masson.Google Scholar
Clark, A. M., Ledger, W., Galletly, C., et al. (1995) Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum. Reprod. 10:2705–2712.CrossRefGoogle ScholarPubMed
Clayton, R. N., Ogden, V., Hodgkinson, J., et al. (1992) How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin. Endocrinol. (Oxf.) 37:127–134.CrossRefGoogle ScholarPubMed
Clifford K., Rai R., Watson H., Franks S., and Regan L. (1996) Randomized controlled trial of pituitary suppression of high LH concentrations in women with recurrent miscarriage. Abstracts 12th Annual Meeting ESHRE, Maastricht: A054.
Conway, G. S., Honour, J. W., and Jacobs, H. S. (1989) Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin. Endocrinol. (Oxf.) 30:459–470.CrossRefGoogle ScholarPubMed
Conway, G. S., Clark, P. M., and Wong, D. (1993) Hyperinsulinaemia in the polycystic ovary syndrome confirmed with a specific immunoradiometric assay for insulin. Clin. Endocrinol. (Oxf.) 38:219–222.CrossRefGoogle ScholarPubMed
Cresswell, J. L., Barker, D. J., Osmond, C., et al. (1997) Fetal growth, length of gestation, and polycystic ovaries in adult life. Lancet 351:295–296.Google Scholar
Cudmore, D. W. and Tupper, W. R. C. (1966) Induction of ovulation with clomiphene citrate: A double-blind study. Fertil. Steril. 17:363–373.CrossRefGoogle ScholarPubMed
Dale, O., Tanbo, T., Haug, E., and Abyholm, T. (1998) The impact of insulin resistance on the outcome of ovulation induction with low-dose FSH in women with polycystic ovary syndrome. Hum. Reprod. 13:567–570.CrossRefGoogle ScholarPubMed
Dewailly, D. (1997) Definition and significance of polycystic ovaries. Baillière's Clin Obstet Gynaecol. 11:349–368.CrossRefGoogle ScholarPubMed
Dewailly, D., Robert, Y., Helin, I., et al. (1994) Ovarian stromal hypertrophy in hyperandrogenic women. Clin. Endocrinol. (Oxf.) 41:557–562.CrossRefGoogle ScholarPubMed
Donesky, B. W. and Adashi, E. Y. (1995) Surgically induced ovulation in the polycystic ovary syndrome: wedge resection revisited in the age of laparoscopy. Fertil. Steril. 63:439–463.Google ScholarPubMed
Dunaif, A. (1992a) Insulin resistance and ovarian hyperandrogenism. Endocrinologist 2:248–260.CrossRefGoogle Scholar
Dunaif, A. (1992b) The Polycystic Ovary Syndrome. Cambridge, MA:Blackwell Scientific.Google Scholar
Dunaif, A. (1997) Insulin resistance and the polycystic ovarian syndrome: mechanisms and implications for pathogenesis. Endocr. Rev. 18:774–800.Google Scholar
Dunaif, A., Segal, K., Futterweit, W., and Dobrjansky, A. (1989) Profound peripheral resistance independent of obesity in polycystic ovary syndrome. Diabetes 38:1165–1174.CrossRefGoogle ScholarPubMed
Eden, J. A. (1991) The polycystic ovary syndrome presenting as resistant acne successfully treated with cyproterone acetate. Med. J. Austral. 155:677–680.Google ScholarPubMed
Eden, J. A., Place, J., Carter, G. D., et al. (1989) The diagnosis of polycystic ovaries in subfertile women. Br. J. Obstet. Gynaecol. 96:809–815.CrossRefGoogle Scholar
Ehrmann, D. A. (1997) Relation of functional ovarian hyperandrogenism to non-insulin dependent diabetes mellitus. Baillière's Clin. Obstet. Gynaecol. 11:335–347.CrossRefGoogle ScholarPubMed
Ehrmann D. A., Barnes R. B., and Rosenfield R. L. (1994) Hyperandrogenism, hirsutism and the polycystic ovary syndrome. In Groot, L. J., Berse, M., Burger, H. G., et al. (eds.) Endocrinology, 3rd edn, vol. 3, pp. 2093–2112. Philadelphia, PA: W. B. Saunders.Google Scholar
El Tabbakh, G. H., Lotfy, I., Azab, I., et al. (1986) Correlation of the ultrasonic appearance of the ovaries in polycystic ovarian disease and the clinical, hormonal, and laparoscopic findings. Am. J. Obstet. Gynecol. 154:892–895.CrossRefGoogle ScholarPubMed
Farquhar, C. M., Birdsall, M., Manning, P., Mitchell, J. M., and France, J. T. (1994a) The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Austral. N.Z. J. Obstet. Gynaecol. 34:67–72.CrossRefGoogle Scholar
Farquhar, C. M., Birdsall, M., Manning, P., and Mitchell, J. M. (1994b) Transabdominal versus transvaginal ultrasound in the diagnosis of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Ultrasound Obstet. Gynecol. 4:54–59.CrossRefGoogle Scholar
Farquhar, C. M., Williamson, K., Gudex, G., et al. (2002) A randomized controlled trial of laparoscopic ovarian diathermy versus gonadotrophin therapy for women with clomiphene resistant polycystic ovarian syndrome. Fertil. Steril. 78:401–411.CrossRefGoogle Scholar
Farquhar, C. M., Williamson, K., Brown, P. M., et al. (2004) An economic evaluation of laparoscopic ovarian diathermy versus gonadotrophin therapy for women with clomiphene citrate resistant polycystic ovary syndrome. Hum. Reprod. 19:1110–1115.CrossRefGoogle ScholarPubMed
Farquhar, C., Vandekerckhove, P., and Lilford, R. (2005) Laparoscopic “drilling” by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome (Cochrane Review). In The Cochrane Library, Issue 2. Chichester, UK:John Wiley.Google Scholar
Fauser, B. C., Pache, T. D., Lamberts, S. W., et al. (1991) Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease. J. Clin. Endocrinol. Metab. 73:811–817.CrossRefGoogle ScholarPubMed
Fauser, B. C., Pache, T. D., Hop, W. C., Jong, F. H., and Dahl, K. D. (1992) The significance of a single serum LH measurement in women with cycle disturbance: discrepancies between immunoreactive and bioactive hormone estimates. Clin. Endocrinol. (Oxf.) 37:445–452.CrossRefGoogle Scholar
Fox, R., Corrigan, E., Thomas, P. A., and Hull, M. G. (1991) The diagnosis of polycystic ovaries in women with oligo-amenorrhoea: predictive power of endocrine tests. Clin. Endocrinol. (Oxf.) 34:127–131.CrossRefGoogle Scholar
Franks, S. (1989) Polycystic ovary syndrome: a changing perspective. Clin. Endocrinol. (Oxf.) 31:87–120.CrossRefGoogle ScholarPubMed
Franks, S. (1995) Polycystic ovary syndrome. N. Engl. J. Med. 333:853–861.CrossRefGoogle ScholarPubMed
Franks, S. and White, D. M. (1993) Prevalence of and aetiological factors in polycystic ovary syndrome. Ann. N. Y. Acad. Sci. 687:112–114.CrossRefGoogle Scholar
Gadir, A. A., Mowafi, R. S., Alnaser, H. M., et al. (1990) Ovarian electrocautery versus human menopausal gonadotrophins and pure follicle stimulating hormone therapy in the treatment of patients with polycystic ovarian disease. Clin. Endocrinol. (Oxf.) 33:585–592.CrossRefGoogle ScholarPubMed
Gemzell, C. A., Diczfalusy, E., and Tillinger, K. G. (1958) Clinical effect of human pituitary follicle-stimulating hormone (FSH). J. Clin. Endocrinol. Metab. 18:1333.CrossRefGoogle Scholar
Ginsburg, J., Isaacs, A. J., Gore, M. B. R., and Havard, C. W. H. (1975) Use of clomiphene and luteinizing hormone/follicle stimulating hormone-releasing hormone in investigation of ovulatory failure. Br. Med. J. 3:130–133.CrossRefGoogle ScholarPubMed
Gjoanness, H. (1984) Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope. Fertil. Steril. 41:20–25.CrossRefGoogle Scholar
Goldzieher, J. W. and Green, J. A. (1962) The polycystic ovary. I. Clinical and histological features. J. Clin. Endocrinol. Metab. 22:325–328.CrossRefGoogle Scholar
Greenblatt, E. and Casper, R. (1993) Adhesion formation after laparoscopic ovarian cautery for polycystic ovarian syndrome: lack of correlation with pregnancy rate. Fertil. Steril. 60:766–770.CrossRefGoogle ScholarPubMed
Greenblatt, R. B. (1961) Chemical induction of ovulation. Fertil. Steril. 12:402.CrossRefGoogle ScholarPubMed
Guzick, D. S., Talbott, E. O., Sutton-Tyrrell, K., et al. (1996) Carotid atherosclerosis in women with polycystic ovary syndrome: initial results from a case-control study. Am. J. Obstet. Gynecol. 174:1224–1229.CrossRefGoogle ScholarPubMed
Hague, W. M., Adams, J., Reeders, S. T., Peto, T. E., and Jacobs, H. S. (1988) Familial polycystic ovaries: a genetic disease. Clin. Endocrinol. (Oxf.) 29:593–605.CrossRefGoogle ScholarPubMed
Hamilton-Fairley, D., Kiddy, D., Watson, H., Sagle, M., and Franks, S. (1991) Low dose gonadotrophin therapy for induction of ovulation in 100 women with polycystic ovary syndrome. Hum. Reprod. 6:1095–1099.CrossRefGoogle ScholarPubMed
Hamilton-Fairley, D., Kiddy, D., Watson, H., Paterson, C., and Franks, S. (1992) Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin. Br. J. Obstet. Gynaecol. 99:128–131.CrossRefGoogle ScholarPubMed
Homburg, R. (1996) Polycystic ovary syndrome: from gynaecological curiosity to multisystem endocrinopathy. Hum. Reprod. 11:29–39.CrossRefGoogle ScholarPubMed
Homburg, R. (1998) Adverse effect of luteinizing hormone on fertility: fact or fantasy. Baillière's Clin. Obstet. Gynaecol. 12:555–563.CrossRefGoogle ScholarPubMed
Homburg, R. (2003) The management of infertility associated with polycystic ovary syndrome. Reprod. Biol. Endocrinol. 1:109.CrossRefGoogle ScholarPubMed
Homburg, R., Armar, N. A., Eshel, A., Adams, J., and Jacobs, H. S. (1988) Influence of serum luteinizing hormone concentrations on ovulation, conception and early pregnancy loss in polycystic ovary syndrome. Br. Med. J. 297:1024–1026.CrossRefGoogle ScholarPubMed
Homburg, R., Pariente, C., Lunenfeld, B., and Jacobs, H. S. (1992) The role of insulin-like growth factor-1 (IGF-1) and IGF binding protein-1 (IGF-BP-1) in the pathogenesis of polycystic ovary syndrome. Hum. Reprod. 7:1379–1383.CrossRefGoogle Scholar
Hughes, E., Collins, J., and Vandekerckhove, P. (1999a) Ovulation induction with urinary follicle stimulating hormone versus human menopausal gonadotrophin for clomiphene-resistant polycystic ovary syndrome (Cochrane Review). In The Cochrane Library, Issue 1. Oxford, UK: Update Software.Google Scholar
Hughes, E., Collins, J., and Vandekerckhove, P. (1999b) Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene resistant polycystic ovarian syndrome (Cochrane Review). In The Cochrane Library, Issue 1. Oxford, UK: Update Software.Google Scholar
Hull, M. G. (1987) Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol. Endocrinol. 1:235–245.CrossRefGoogle ScholarPubMed
Insler, V., Potashnik, G.Lunenfeld, E., Meizner, I., and Levy, J. (1988) Ovulation induction with hMG following down regulation of the pituitary–ovarian axis by LH-RH analogues. Gynecol. Endocrinol. 2:67.Google Scholar
Jacobs, H. S. (1996) Polycystic ovary syndrome: the present position. Gynecol. Endocrinol. 10:427–433.CrossRefGoogle ScholarPubMed
Khan, C. R., Flier, J. S., Bar, R. S., Archal, J. A., and Gorden, P. (1976) The syndromes of insulin resistance and acanthosis nigricans: insulin receptor disorders in man. N. Engl. J. Med. 294:739–745.CrossRefGoogle Scholar
Kiddy, D. S., Hamilton-Fairley, D., Bush, A., et al. (1992) Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 36:105–111.CrossRefGoogle ScholarPubMed
Kistner, R. W. (1966) Use of clomiphene citrate, human chorionic gonadotropin, and human menopausal gonadotropin for induction of ovulation in the human female. Fertil. Steril. 17:569.CrossRefGoogle ScholarPubMed
Lazovic, G., Milacic, D., Terzic, M., et al. (1998) Medicaments or surgical therapy of PCOS. Fertil. Steril. 70:472.Google Scholar
Li, T. C., Saravelos, H., Chow, M. S., Chisabingo, R., and Cooke, I. D. (1998) Factors affecting the outcome of laparoscopic ovarian drilling for polycystic ovarian syndrome in women with anovulatory infertility. Br. J. Obstet. Gynaecol. 105:338–344.CrossRefGoogle ScholarPubMed
Liddell, H., Farquhar, C. M., and Sowden, C. (1997). The association of polycystic ovaries and recurrent miscarriage. N. Z. Med. J. 37:402–406.Google Scholar
Lobo, R. A., Granger, L., Goebelsmann, U., and Mishell, J. R. (1981) Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotrophin secretion in women with PCO. J. Clin. Endocrinol. Metab. 52:156–158.CrossRefGoogle ScholarPubMed
Lord, J., Flight, I. H., and Norman, R. J. (2003) Metformin in polycystic ovary syndrome: systematic review and meta-analysis. Br. Med. J. 327:951–953.CrossRefGoogle ScholarPubMed
Lowe, P., Kovacs, G., and Howlett, D. (2005) Incidence of polycystic ovaries and polycystic ovary syndrome amongst women in Melbourne, Australia. Austral. N. Z. J. Obstet. Gynaecol. 45:17–19.CrossRefGoogle ScholarPubMed
Lunde, O., Magnus, P., Sandvik, L., and Hoglo, S. (1989) Familial clustering in the polycystic ovarian syndrome. Gynecol. Obstet. Invest. 28:23–30.CrossRefGoogle ScholarPubMed
MacLeod, S. C., Mitton, D. M., Parker, A. S., and Tupper, W. R. C. (1970) Experience with induction of ovulation. Am. J. Obstet. Gynecol. 1:814–824.CrossRefGoogle Scholar
McArthur, J. W., Ingersoll, F. W., and Worcester, J. (1958) The urinary excretion of interstitial-cell and follicle-stimulating hormone activity by women with diseases of the reproductive system. J. Clin. Endocrinol. Metab. 18:1202–1215.CrossRefGoogle ScholarPubMed
Michelmore, K., Balen, A., Dunger, D., et al. (1998) Prevalence and clinical features of polycystic ovary syndrome in 224 young female volunteers. Hum. Reprod. 13: abstract 0024.Google Scholar
Nestler, J. E. (1997) Insulin regulation of human ovarian androgens. Hum. Reprod. 12(Suppl.):52–62.CrossRefGoogle ScholarPubMed
Orsini, L. F., Venturoli, S., and Lorusso, R. (1985) Ultrasonic findings in polycystic ovarian disease. Fertil. Steril. 43:709–714.CrossRefGoogle ScholarPubMed
Pasquali, R., Antenucci, D., Casmirri, F., et al. (1989) Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J. Clin. Endocrinol. Metab. 68:173–179.CrossRefGoogle ScholarPubMed
Pasquali, R., Casimirri, F., and Venturoli, D. (1994) Body fat distribution has weight-independent effects on clinical, hormonal and metabolic features of women with polycystic ovary syndrome. Metabolism 6:706–713.CrossRefGoogle Scholar
Plymate, S. R., Fariss, B. L., Basset, M. L., and Matej, L. (1981) Obesity and its role in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 66:1246–1248.CrossRefGoogle Scholar
Polson, D. W., Mason, H. D., Saldahna, M. B., and Franks, S. (1987) Ovulation of a single dominant follicle during treatment with low dose pulsatile follicle stimulating hormone in women with polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 26:205–212.CrossRefGoogle ScholarPubMed
Polson, D. W., Adams, J., Wadsworth, J., and Franks, S. (1988) Polycystic ovaries: a common finding in normal women. Lancet 16(April):870–872.CrossRefGoogle Scholar
Rai, R., Clifford, K., and Regan, L. (1996) The modern preventative treatment of recurrent miscarriage. Br. J. Obstet. Gynaecol. 103:106–110.CrossRefGoogle ScholarPubMed
Rajkhowa, M., Glass, M. R., Rutherford, A. J., Michelmore, K., and Balen, A. H. (2000) Polycystic ovary syndrome: a risk factor for cardiovascular disease?Br. J. Obstet. Gynaecol. 107:11–18.CrossRefGoogle ScholarPubMed
Rebar, R., Judd, H. L., Yen, S. C. C., et al. (1976) Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. J. Clin. Invest. 57:1320–1329.CrossRefGoogle ScholarPubMed
Recombinant Human FSH Study Group (1995) Clinical assessment of recombinant human follicle-stimulating ovarian follicle development before in vitro fertilization. Fertil. Steril. 63:77–86.
Regan, L., Owen, E. J., and Jacobs, H. S. (1990) Hypersecretion of luteinising hormone, infertility and miscarriage. Lancet 336:1141–1144.CrossRefGoogle ScholarPubMed
Robinson, S., Rodin, D. A., Deacon, A., Wheeler, M. J., and Clayton, R. N. (1992) Which hormone tests for the diagnosis of polycystic ovary syndrome?Br. J. Obstet. Gynaecol. 99:232–238.CrossRefGoogle ScholarPubMed
Rosenfield, R. L., Barnes, R. B., Cara, J. F., and Lucky, A. W. (1990) Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome. Fertil. Steril. 53:785–791.CrossRefGoogle ScholarPubMed
Sagle, M., Bishop, K., Ridley, N., et al. (1988) Recurrent early miscarriage and polycystic ovaries. Br. Med. J. 297:1027–1028.CrossRefGoogle ScholarPubMed
Sagle, M. A., Hamilton-Fairley, D., Kiddy, D. S., and Franks, S. (1991) A comparative randomized study of low dose human menopausal gonadotropin and follicle stimulating hormone in women with polycystic ovarian syndrome. Fertil. Steril. 55:56–60.CrossRefGoogle ScholarPubMed
Santon, R. J. and Bardin, C. W. (1973) Episodic LH secretion in man: pulse analysis, clinical interpretation, physiologic mechanisms. J. Clin. Invest. 52:2617–2628.CrossRefGoogle Scholar
Saxton, D. W., Farquhar, C. M., Rae, T., et al. (1990) Accuracy of ultrasound measurements of female pelvic organs. Br. J. Obstet. Gynaecol. 97:695–699.CrossRefGoogle ScholarPubMed
Seibel, M. M., Kamrava, M. M., McArdle, C., and Taymor, M. L. (1984) Treatment of polycystic ovarian disease with chronic low dose follicle stimulating hormone: biochemical changes and ultrasound correlation. Int. J. Fertil. 29:39–43.Google ScholarPubMed
Shoham, Z. and Insler, V. (1996) Recombinant technique and gonadotropins production: new era in reproductive medicine. Fertil. Steril. 66:187–201.Google ScholarPubMed
Shoham, Z., Patel, A., and Jacobs, H. S. (1991) Polycystic ovary syndrome: safety and effectiveness of stepwise and low dose administration of purified follicle stimulating hormone. Fertil. Steril. 55:1051–1056.CrossRefGoogle ScholarPubMed
Shoupe, D., Kumar, D. D., and Lobo, R. A. (1983) Insulin resistance in polycystic ovary syndrome. Am. J. Obstet. Gynecol. 147:588–592.CrossRefGoogle ScholarPubMed
Stein, I. F. and Leventhal, M. L. (1935) Amenorrhoea associated with bilateral polycystic ovaries. Am. J. Obstet. Gynecol. 29:181–191.CrossRefGoogle Scholar
Stein, I. F., Cohen, M. R., and Elson, R. E. (1948) Results of bilateral ovarian wedge resection in 47 cases of sterility. Am. J. Obstet. Gynecol. 58:267–273.CrossRefGoogle Scholar
Swanson, M., Sauerbrei, E. E., and Cooperberg, P. L. (1981) Medical implications of ultrasonically detected polycystic ovaries. J. Clin. Ultrasound 9:219–222.CrossRefGoogle ScholarPubMed
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 81:19–25.
Thomas, A., Okamoto, S., O'Shea, F., et al. (1989) Do raised serum luteinizing hormone levels during stimulation for in-vitro fertilization predict outcome?Br. J. Obstet. Gynaecol. 96:1328–1332.CrossRefGoogle ScholarPubMed
Thompson, C. R. and Hansen, L. M. (1970) Pergonal (menotropins): a summary of clinical experience in the induction of ovulation and pregnancy. Fertil. Steril. 21:844–853.CrossRefGoogle Scholar
Tulppala, M., Stenman, U. H., Cacciatore, B., and Ylikorkala, O. (1993) Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: prospective study in 50 women. Br. J. Obstet. Gynaecol. 100:348–352.CrossRefGoogle ScholarPubMed
Vallisneri, A. (1721) Cited in Insler and Lunesfeld (1990) Gynecol. Endocrinol. 4:51–69.Google Scholar
Wely, M., Bayram, N., Bossunyt, P. M. M., et al. (2004) An economic comparison of a laparoscopic electrocoagulation strategy and ovulation induction with recombinant FSH in women with clomiphene citrate-resistant polycystic ovary syndrome. Hum. Reprod. 19:1741–1745.CrossRefGoogle ScholarPubMed
Vegetti W., Ragni G., Baroni E., et al. (1998) Laparoscopic ovarian drilling versus low-dose pure FSH in anovulatory clomiphene-resistant patients with polycystic ovarian syndrome: randomized prospective study. Abstracts 14th Annual Meeting ESHRE, Goteborg: A120.
Waldstreicher, J., Santoro, N. F., Hall, J. E., Filicori, M., and Crowley Jr., W. F. (1988) Hyperfunction of the hypothalamic pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotrope desensitization. J. Clin. Endocrinol. Metab. 66:165–172.CrossRefGoogle Scholar
Wang, C. F. and Gemzell, C. (1980) The use of human gonadotropins for induction of ovulation in women with polycystic ovarian disease. Fertil. Steril. 33:479–486.CrossRefGoogle ScholarPubMed
Wild R. A. (1997) Cardiovascular and lipoprotein abnormalities in androgen excess. In Azziz, R., Nestler, J. E., and Dewailly, D. (eds.) Androgen Excess Disorders in Women pp. 681–688. Philadelphia, PA: Lippincott-Raven.Google Scholar
Willis, D. and Franks, S. (1995) Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor. J. Clin. Endocrinol. Metab. 80:3788–3790.CrossRefGoogle Scholar
Yen, S. S. C. (1980) The polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 12:177–207.CrossRefGoogle ScholarPubMed
Yen, S. S. C. (1983) Clinical application of gonadotropin releasing hormone analogues. Fertil. Steril. 39:257.Google Scholar
Yen, S. S. C., Vela, P., and Rankin, J. (1970) Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease. J. Clin. Endocrinol. Metab. 30:435–442.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×